Under construction – not a live service

Skip to content

Frontlight Research

Institution

Ospedale dei Bambini Vittore Buzzi

Milan, ItalyWebsite

2running trials
1closed trial
2,875publications (OpenAlex)

Running trials

Recruiting
Multi-biomarkers in DEE
NCT07909382· Istituto Giannina Gaslini· Source
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Crohn's disease1 recruiting
Epilepsy1 recruiting
Ulcerative colitis1 recruiting

Closed trials

Withdrawn
A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms
NCT05128344· Phase 3· Amzell· Source

Registry name variants (2)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Ospedale dei Bambini "Vittore Buzzi"
Milan, 20154
3 trials
- NCT07909382Multi-biomarkers in DEE
  Contact: Pierangelo Veggiotti
- NCT05128344A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms
- NCT04844606A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  Contact: Lorenzo Norsa (principal investigator)
Ospedale dei Bambini "Vittore Buzzi" (Site 1606)
Milan, Lombardy 20154

Conditions

Diseases this institution publishes on or runs trials for.

Coeliac disease5 works · 0 trials

Institution data: ROR 044ycg712 (CC0-1.0)Updated 12 Nov 2026

Report an error